Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  London Stock Exchange  >  Huntsworth plc    HNT   GB00B0CRWK29

HUNTSWORTH PLC

(HNT)
  Report
End-of-day quote. End-of-day quote London Stock Exchange - 04/30
107.5 GBX   0.00%
03/13PREMIER MITON GROUP PLC : - Form 8.3 - Huntsworth AMENDMENT
PR
03/13HUNTSWORTH : Form 8.3 -
AQ
03/13PREMIER MITON GROUP PLC : - Form 8.3 - Huntsworth
PR
SummaryQuotesChartsNewsRatingsCompanyFinancials 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector news

U.S. buyout firm CD&R to buy UK's Huntsworth for £400 million in pharma bet

share with twitter share with LinkedIn share with facebook
03/03/2020 | 08:11am EDT

U.S.-based private equity firm Clayton, Dubilier & Rice has agreed to buy British healthcare marketing and services company Huntsworth for about 400 million pounds ($511 million) in a bet on continued strong growth in global healthcare markets.

Clayton, Dubilier & Rice (CD&R) said on Tuesday it would pay 108 pence a share in cash for Huntsworth, which provides marketing and medical communications services to pharmaceutical companies.

That's a 50% premium to the stock's closing price on Monday.

However, Huntsworth shares surged beyond the bid price to as high as 110.7 pence, suggesting some investors think a counter-bid is possible for the fast-growing British firm.

"This looks an excellent price for the bidding company" said Peel Hunt analysts, who have a target price of 120 pence for Huntsworth shares. "This modest valuation ... (leaves) the door ajar for speculation on the potential for a competing approach".

CD&R said Huntsworth's underlying markets, the United States and Europe, were attractive and underpinned by stable pharma industry trends, adding it intended to help Huntsworth with future acquisitions.

"Our vision for Huntsworth is shared with management, who have demonstrated an ability to drive organic growth and execute accretive add-on acquisitions," said Liam Fitzgerald, adviser to CD&R funds.

In a separate statement, Huntsworth reported a 27% jump in pretax profit for 2019, as its communications division returned to growth and its medical arm went from strength to strength.

"Healthcare remains our focus for growth and investment, as it continues to be a fast-growing sector led by increasing global demand for new drugs to help ageing populations," said Huntsworth chief executive Paul Taaffe.

"This demand is driving a complex marketplace that requires a combination of higher margin consultancy services, medical affairs and more effective marketing".

The acquisition is the latest by a U.S. private equity firm in Britain, where a drop in the value of the pound has spurred dealmaking since the country voted to leave the European Union.

Buyout firm Advent, for example, is taking British defence and aerospace group Cobham private, while Blackstone is buying Madame Tussauds owner Merlin.

Huntsworth's directors were advised by Rothschild & Co on the financial terms of the deal, while BofA Securities, Houlihan Lokey and RBC Capital Markets were among advisers to CD&R.

By Yadarisa Shabong


Stocks mentioned in the article
ChangeLast1st jan.
AT HOME GROUP INC. 3.09% 22.72 Delayed Quote.313.09%
COBHAM 0.00% 164.5 Delayed Quote.0.15%
HUNTSWORTH PLC 0.00% 107.5 End-of-day quote.32.06%
JUST GROUP PLC -0.68% 46.64 Delayed Quote.-40.96%
ROTHSCHILD & CO 3.66% 24.1 Real-time Quote.-5.86%
THE BLACKSTONE GROUP INC. -0.24% 54.64 Delayed Quote.-2.32%
THE GLOBAL LTD. -0.92% 216 End-of-day quote.-54.14%
VISION INC. 0.00% 1034 End-of-day quote.-42.94%
WILL GROUP, INC. 1.55% 852 End-of-day quote.-31.95%
share with twitter share with LinkedIn share with facebook
All news about HUNTSWORTH PLC
03/13PREMIER MITON GROUP PLC : - Form 8.3 - Huntsworth AMENDMENT
PR
03/13HUNTSWORTH : Form 8.3 -
AQ
03/13PREMIER MITON GROUP PLC : - Form 8.3 - Huntsworth
PR
03/12ABERFORTH PARTNERS LLP : - Form 8.3 - Huntsworth Plc
PR
03/10ABERFORTH PARTNERS LLP : - Form 8.3 - Huntsworth plc
PR
03/04HUNTSWORTH : Form 8.3 -
AQ
03/04PREMIER MITON GROUP PLC : - Form 8.3 - Huntsworth plc
PR
03/04HUNTSWORTH : Rule 8.3 - (HHL)
AQ
03/04HUNTSWORTH : US equity giant in £400m bid to buy Huntsworth
AQ
03/03ABERFORTH PARTNERS LLP : - Form 8.3 - Huntsworth plc
PR
More news
Financials
Sales 2019 265 M 345 M 345 M
Net income 2019 20,3 M 26,5 M 26,5 M
Net Debt 2019 115 M 150 M 150 M
P/E ratio 2019 15,1x
Yield 2019 3,19%
Capitalization 412 M 508 M 538 M
EV / Sales 2018 2,00x
EV / Sales 2019 1,57x
Nbr of Employees 1 991
Free-Float -
Chart HUNTSWORTH PLC
Duration : Period :
Huntsworth plc Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Managers
NameTitle
Paul Anthony Taaffe Chief Executive Officer & Executive Director
Liam Michael FitzGerald Chairman
Ben Jackson Chief Financial Officer
Andrew Kenneth Boland Senior Independent Non-Executive Director
Helen Apostolidis Chief Talent Officer
Sector and Competitors
1st jan.Capitalization (M$)
HUNTSWORTH PLC32.06%508
AUTOHOME INC.20.81%11 510
OMNICOM GROUP., INC.-34.93%11 328
WPP PLC-37.61%10 557
PUBLICIS GROUPE SA-20.32%9 343
WEIBO CORPORATION-13.70%9 058